268 related articles for article (PubMed ID: 17980165)
21. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
Lu W; Peissel B; Babakhanlou H; Pavlova A; Geng L; Fan X; Larson C; Brent G; Zhou J
Nat Genet; 1997 Oct; 17(2):179-81. PubMed ID: 9326937
[TBL] [Abstract][Full Text] [Related]
22. Identification of phosphorylation sites in the PKD1-encoded protein C-terminal domain.
Li HP; Geng L; Burrow CR; Wilson PD
Biochem Biophys Res Commun; 1999 Jun; 259(2):356-63. PubMed ID: 10362514
[TBL] [Abstract][Full Text] [Related]
23. The polycystin-1 C-terminal fragment triggers branching morphogenesis and migration of tubular kidney epithelial cells.
Nickel C; Benzing T; Sellin L; Gerke P; Karihaloo A; Liu ZX; Cantley LG; Walz G
J Clin Invest; 2002 Feb; 109(4):481-9. PubMed ID: 11854320
[TBL] [Abstract][Full Text] [Related]
24. Epithelial cell polarity and disease.
Wilson PD
Am J Physiol; 1997 Apr; 272(4 Pt 2):F434-42. PubMed ID: 9140043
[TBL] [Abstract][Full Text] [Related]
25. Polycystin-1 dysfunction impairs electrolyte and water handling in a renal precystic mouse model for ADPKD.
Verschuren EHJ; Mohammed SG; Leonhard WN; Overmars-Bos C; Veraar K; Hoenderop JGJ; Bindels RJM; Peters DJM; Arjona FJ
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F537-F546. PubMed ID: 29767557
[TBL] [Abstract][Full Text] [Related]
26. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
Harris PC
Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
[TBL] [Abstract][Full Text] [Related]
27. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Kurbegovic A; Trudel M
Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
[TBL] [Abstract][Full Text] [Related]
28. The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model.
Talbi K; Cabrita I; Kraus A; Hofmann S; Skoczynski K; Kunzelmann K; Buchholz B; Schreiber R
FASEB J; 2021 Oct; 35(10):e21897. PubMed ID: 34473378
[TBL] [Abstract][Full Text] [Related]
29. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
Ahrabi AK; Terryn S; Valenti G; Caron N; Serradeil-Le Gal C; Raufaste D; Nielsen S; Horie S; Verbavatz JM; Devuyst O
J Am Soc Nephrol; 2007 Jun; 18(6):1740-53. PubMed ID: 17475819
[TBL] [Abstract][Full Text] [Related]
30. A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype.
Pritchard L; Sloane-Stanley JA; Sharpe JA; Aspinwall R; Lu W; Buckle V; Strmecki L; Walker D; Ward CJ; Alpers CE; Zhou J; Wood WG; Harris PC
Hum Mol Genet; 2000 Nov; 9(18):2617-27. PubMed ID: 11063721
[TBL] [Abstract][Full Text] [Related]
31. Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl channel activity in Xenopus oocytes.
Chernova MN; Vandorpe DH; Clark JS; Alper SL
Kidney Int; 2005 Aug; 68(2):632-41. PubMed ID: 16014040
[TBL] [Abstract][Full Text] [Related]
32. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
[TBL] [Abstract][Full Text] [Related]
33. The polycystic kidney disease 1 gene product mediates protein kinase C alpha-dependent and c-Jun N-terminal kinase-dependent activation of the transcription factor AP-1.
Arnould T; Kim E; Tsiokas L; Jochimsen F; Grüning W; Chang JD; Walz G
J Biol Chem; 1998 Mar; 273(11):6013-8. PubMed ID: 9497315
[TBL] [Abstract][Full Text] [Related]
34. Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells.
Aguiari G; Varani K; Bogo M; Mangolini A; Vincenzi F; Durante C; Gessi S; Sacchetto V; Catizone L; Harris P; Rizzuto R; Borea PA; Del Senno L
Biochim Biophys Acta; 2009 Jun; 1792(6):531-40. PubMed ID: 19285554
[TBL] [Abstract][Full Text] [Related]
35. Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1.
Shillingford JM; Shayman JA
Am J Physiol Renal Physiol; 2023 Apr; 324(4):F404-F422. PubMed ID: 36794754
[TBL] [Abstract][Full Text] [Related]
36. Effects of Suramin on Polycystic Kidney Disease in a Mouse Model of Polycystin-1 Deficiency.
Chang MY; Hsu SH; Ma LY; Chou LF; Hung CC; Tian YC; Yang CW
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955634
[TBL] [Abstract][Full Text] [Related]
37. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
38. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
39. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney.
Ward CJ; Turley H; Ong AC; Comley M; Biddolph S; Chetty R; Ratcliffe PJ; Gattner K; Harris PC
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1524-8. PubMed ID: 8643665
[TBL] [Abstract][Full Text] [Related]
40. Phosphorylation, protein kinases and ADPKD.
Li X
Biochim Biophys Acta; 2011 Oct; 1812(10):1219-24. PubMed ID: 21392577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
